Quest Diagnostics' Laboratory in India Accredited by Two Leading Laboratory Accrediting Organizations

Madison, New Jersey and Gurgaon, India, November 17 (ots/PRNewswire) -

- Less than one tenth of one percent of labs in India are CAP andNABL accredited

- Quest Diagnostics' laboratory also becomes one of only fivelabs in India to achieve NGSP certification for Hemoglobin A1ctesting for diabetes

Quest Diagnostics Incorporated (NYSE: DGX), the world's leadingprovider of diagnostic testing, information and services, todayannounced that its wholly-owned subsidiary Quest Diagnostics IndiaPvt. Ltd. has received certificates of accreditation from the Collegeof American Pathologists (CAP), a leading international laboratoryaccrediting organization, and the National Accreditation Board forTesting and Calibration Laboratories (NABL), the solegovernment-authorized laboratory accreditation body in India, for itsdiagnostic and clinical trials laboratory in Gurgaon, India.Accreditation by CAP and NABL is widely regarded in the internationaldiagnostic industry as signifying that a laboratory performsdiagnostic testing at the highest quality standards.

In addition, the National Glycohemoglobin Standardization Program(NGSP) has awarded Level I Laboratory Certification to the QuestDiagnostics' laboratory in Gurgaon. Level I Laboratory Certification,which is recommended by NGSP for laboratories conductingdiabetes-related clinical trials, indicates that a facility's testingfulfills NGSP's rigorous standards for delivering accurate hemoglobinA1c (HbA1c) testing for diabetes. The Quest Diagnostics lab is one ofonly five laboratories in India to be certified by the internationalprogram. The prevalence of type 2 diabetes in India is expected togrow more rapidly than in any developed or developing nation,climbing from 28 million patients in 2007 to more than 60 million by2017.

"Accreditation by both CAP and NABL is a major accomplishmentbecause it indicates to physicians, hospitals, pharmaceuticalcompanies and patients that all major areas of a laboratory'soperations exhibit the highest level of quality assurance," saidPalat Krishna Menon, M.D., Ph.D., medical director for QuestDiagnostics India Pvt. Ltd. "Level 1 certification by NGSP is also animportant achievement because it means that physicians andpharmaceutical companies can trust that our HbA1c testing results inIndia correlate to the most rigorous global standards and provide thebasis for making reliable treatment decisions for patients withdiabetes."

The accreditation programs of CAP and NABL are designed topromote laboratory excellence by certifying only those laboratoriesthat fulfill rigorous criteria for quality assurance. Bothaccrediting organizations conduct onsite audits to evaluate qualityprocesses and other facets of a lab's operations, and only accreditthose labs that demonstrate the highest quality standards. CAP andNABL investigators accredited the Quest Diagnostics' facility inGurgaon approximately two months after performing separate onsiteaudits in September 2008. More than 100,000 diagnostic laboratoriesoperate in India according to estimates, but only approximately adozen are NABL and CAP accredited.

Quest Diagnostics began operating its 65,000 square-foot,state-of-the-art laboratory in Gurgaon, a satellite city of Delhi, inMarch 2008. The business offers the broadest range of diagnostic andwellness testing services in the industry, including esoterictesting, clinical trials central lab and support services, and riskassessment services to life insurance companies under the ExamOne(R)brand.

About CAP

The College of American Pathologists (CAP) is a medical societyserving more than 17,000 physician members and the laboratorycommunity throughout the world. It is the world's largest associationcomposed exclusively of pathologists and is widely considered theleader in laboratory quality assurance. The CAP is an advocate forhigh-quality and cost-effective medical care. For more information,visit www.cap.org.

About NABL

NABL is an autonomous body under the government of India'sdepartment of science and technology. It was established to promotecompetence of testing and calibration laboratories throughthird-party accreditation. NABL assesses medical laboratories againstthe International Organization of Standardization (ISO)'s 15189standard for medical laboratories. NABL has signed mutual recognitionagreements with Asia Pacific Laboratory Accreditation Co-operation(APLAC) and the International Laboratory Accreditation Co-operation(ILAC). For more information, visit www.nabl-india.org.

About NGSP

The National Glycohemoglobin Standardization Program (NGSP) aimsto establish standards for HbA1c clinical laboratory testing acrossthe diagnostic industry. The NGSP was formed in 1996 after theseminal Diabetes Control and Complications Trial (DCCT) demonstratedthat HbA1c levels correlate with a patient's risk of developingdiabetes disease complications, such as heart disease. TheInternational Diabetes Federation and American Diabetes Associationrecommend treatment goals for patients with diabetes largely on HbA1clevels. For more information, visit www.ngsp.org.

About Quest Diagnostics

Quest Diagnostics is the world's leading provider of diagnostictesting, information and services that patients and doctors need tomake better healthcare decisions. The company offers the broadestaccess to diagnostic testing services through its network oflaboratories and patient service centers, and provides interpretiveconsultation through its extensive medical and scientific staff.Quest Diagnostics is a pioneer in developing innovative newdiagnostic tests and advanced healthcare information technologysolutions that help improve patient care. Additional companyinformation is available at www.questdiagnostics.com.

ots Originaltext: Quest Diagnostics IncorporatedIm Internet recherchierbar: http://www.presseportal.de

Contact:Laure Park (Investors): +1-973-520-2900, or Wendy Bost (Media): +1-973-520-2800, both for Quest Diagnostics

Quest Diagnostics Incorporated

Zurück zur Übersiche Medizin-Nachrichten

Preisvergleich Medikamente
Medikament oder PZN:   
In Zusammenarbeit mit Medizinfuchs


Quest Diagnostics' Laboratory in India Accredited by Two Leading Laboratory Accrediting Organizations